Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07765238
NA

PCDD Generation 1 Oral Liquid Acetaminophen Delivery Evaluation

Sponsor: Yale University

View on ClinicalTrials.gov

Summary

This prospective randomized pilot study evaluates the feasibility, acceptability, and preliminary efficacy of the Patient-Controlled Dispenser and Deactivator (PCDD) Generation 1 system for patient-controlled oral liquid acetaminophen administration in postoperative total shoulder replacement inpatients compared with standard nurse-administered oral acetaminophen delivery.

Official title: Evaluation of the Patient-Controlled Dispenser & Deactivator (PCDD) Generation 1 System for Oral Liquid Acetaminophen Delivery

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2026-09

Completion Date

2027-12

Last Updated

2026-09-03

Healthy Volunteers

No

Interventions

DEVICE

PCDD Generation 1 system

Dispenses prescribed oral liquid medication through a secure, patient-activated mechanism . The system provides access to as needed oral liquid doses only within the prescribed dosing eligibility window.

Locations (1)

Yale New Haven Hospital SRC

New Haven, Connecticut, United States